SCHIRNER MICHAEL

Disclosed is the use of a compound according to formula (I) or a pharmaceutically acceptable salt thereof, for the preparation of a diagnostic composition for the detection of a proliferative disease (such as a tumor, a precancerosis, a dys…

Disclosed is the use of a compound according to formula (I) or a pharmaceutically acceptable salt thereof, for the preparation of a diagnostic composition for the detection of a proliferative disease (such as a tumor, a precancerosis, a dys…

Disclosed is the use of a compound according to formula (I) or a pharmaceutically acceptable salt thereof, for the preparation of a diagnostic composition for the detection of a proliferative disease (such as a tumor, a precancerosis, a dys…

Disclosed is the use of a compound according to formula (I) or a pharmaceutically acceptable salt thereof, for the preparation of a diagnostic composition for the detection of a proliferative disease (such as a tumor, a precancerosis, a dys…

Disclosed is the use of a compound according to formula (I) or a pharmaceutically acceptable salt thereof, for the preparation of a diagnostic composition for the detection of a proliferative disease (such as a tumor, a precancerosis, a dys…

Disclosed is the use of a compound according to formula (I) or a pharmaceutically acceptable salt thereof, for the preparation of a diagnostic composition for the detection of a proliferative disease (such as a tumor, a precancerosis, a dys…

Disclosed is the use of a compound according to formula (I) or a pharmaceutically acceptable salt thereof, for the preparation of a diagnostic composition for the detection of a proliferative disease (such as a tumor, a precancerosis, a dys…

Disclosed is the use of a compound according to formula (I) or a pharmaceutically acceptable salt thereof, for the preparation of a diagnostic composition for the detection of a proliferative disease (such as a tumor, a precancerosis, a dys…

Disclosed is the use of a compound according to formula (I) or a pharmaceutically acceptable salt thereof, for the preparation of a diagnostic composition for the detection of a proliferative disease (such as a tumor, a precancerosis, a dys…

Disclosed is the use of a compound according to formula (I) or a pharmaceutically acceptable salt thereof, for the preparation of a diagnostic composition for the detection of a proliferative disease (such as a tumor, a precancerosis, a dys…

Disclosed is the use of a compound according to formula (I) or a pharmaceutically acceptable salt thereof, for the preparation of a diagnostic composition for the detection of a proliferative disease (such as a tumor, a precancerosis, a dys…

This invention relates to the use of conjugates of cyanine dyes with an angiogenesis specific binding component preferably with an EB-D fibronectin specific binding component for the diagnosis of micrometastasis and small proliferative lesi…

This invention relates to the use of conjugates of cyanine dyes with an angiogenesis specific binding component preferably with an EB-D fibronectin specific binding component for the diagnosis of micrometastasis and small proliferative lesi…

This invention relates to the use of conjugates of cyanine dyes with an angiogenesis specific binding component preferably with an EB-D fibronectin specific binding component for the diagnosis of micrometastasis and small proliferative lesi…

This invention relates to the use of conjugates of cyanine dyes with an angiogenesis specific binding component preferably with an EB-D fibronectin specific binding component for the diagnosis of micrometastasis and small proliferative lesi…

This invention relates to the use of conjugates of cyanine dyes with an angiogenesis specific binding component preferably with an EB-D fibronectin specific binding component for the diagnosis of micrometastasis and small proliferative lesi…

This invention relates to the use of conjugates of cyanine dyes with an angiogenesis specific binding component preferably with an EB-D fibronectin specific binding component for the diagnosis of micrometastasis and small proliferative lesi…

This invention relates to the use of conjugates of cyanine dyes with an angiogenesis specific binding component preferably with an EB-D fibronectin specific binding component for the diagnosis of micrometastasis and small proliferative lesi…

This invention relates to the use of conjugates of cyanine dyes with an angiogenesis specific binding component preferably with an EB-D fibronectin specific binding component for the diagnosis of micrometastasis and small proliferative lesi…

This invention relates to the use of conjugates of cyanine dyes with an angiogenesis specific binding component preferably with an EB-D fibronectin specific binding component for the diagnosis of micrometastasis and small proliferative lesi…

This invention relates to the use of conjugates of cyanine dyes with an angiogenesis specific binding component preferably with an EB-D fibronectin specific binding component for the diagnosis of micrometastasis and small proliferative lesi…

This invention relates to the use of conjugates of cyanine dyes with an angiogenesis specific binding component preferably with an EB-D fibronectin specific binding component for the diagnosis of micrometastasis and small proliferative lesi…

This invention relates to the use of conjugates of cyanine dyes with an angiogenesis specific binding component preferably with an EB-D fibronectin specific binding component for the diagnosis of micrometastasis and small proliferative lesi…

This invention relates to the use of conjugates of cyanine dyes with an angiogenesis specific binding component preferably with an EB-D fibronectin specific binding component for the diagnosis of micrometastasis and small proliferative lesi…

This invention relates to the use of conjugates of cyanine dyes with an angiogenesis specific binding component preferably with an EB-D fibronectin specific binding component for the diagnosis of micrometastasis and small proliferative lesi…